AML/MDS
Clinical trials for AML/MDS explained in plain language.
Never miss a new study
Get alerted when new AML/MDS trials appear
Sign up with your email to follow new studies for AML/MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial seeks to reboot immune system to fight childhood leukemia
Disease control Recruiting nowThis study is testing a new type of treatment called CD123-CAR T-cell therapy for children and young adults (up to age 21) whose blood cancers have come back or haven't responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to better target…
Matched conditions: AML/MDS
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for patients with aggressive, Treatment-Resistant leukemia
Disease control Recruiting nowThis early-stage study is testing the safety and initial effectiveness of a new drug called Danvatirsen, first by itself and then combined with an existing drug, Venetoclax. It is for adults with advanced forms of blood cancer (MDS or AML) that have returned or not responded to a…
Matched conditions: AML/MDS
Phase: PHASE1 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC